Men Urged to Prioritize Health Through Early Screening Tests

Hepatitis B is a viral infection that affects the liver and can cause both acute and chronic disease. The hepatitis B virus is transmitted through contact with infected blood or other body fluids. Common routes of transmission include from mother to child during birth, through unsafe injection practices, contaminated blood transfusions, sexual contact, and sharing of needles. Healthcare workers are also at risk through accidental needle stick injuries. The infection can range from a mild illness lasting a few weeks to a serious lifelong condition that may lead to liver cirrhosis or liver cancer.

Laboratory testing plays a crucial role in diagnosing hepatitis B infection and determining the stage of the disease. The most common initial screening test is the hepatitis B surface antigen test, which detects the presence of the virus in the blood. If this test is positive, additional tests are performed to determine whether the infection is acute or chronic. These include hepatitis B core antibody tests, hepatitis B e-antigen, and hepatitis B viral DNA tests. The pattern of these test results helps doctors understand the infection status, level of viral replication, and potential infectiousness of the individual.

For people with chronic hepatitis B, regular monitoring through blood tests is essential. Liver function tests measure enzymes and proteins in the blood that indicate how well the liver is working. Elevated levels of certain liver enzymes suggest liver inflammation or damage. The hepatitis B viral load test measures the amount of virus in the blood and helps assess disease activity and response to treatment. Alpha-fetoprotein testing and imaging studies may also be recommended to screen for liver cancer in patients with chronic infection.

Understanding test results is important for managing hepatitis B. A positive hepatitis B surface antigen that persists for more than six months indicates chronic infection. The presence of hepatitis B surface antibody usually means the person has recovered from infection or has been successfully vaccinated and is now immune. Hepatitis B core antibody indicates past or current infection. Healthcare providers use these test results together with clinical evaluation to make treatment decisions and provide appropriate counseling about preventing transmission to others.

Vaccination is the most effective way to prevent hepatitis B infection. Blood tests can confirm whether vaccination has been successful by checking for the presence of hepatitis B surface antibodies. People at higher risk of infection, including healthcare workers, individuals with multiple sexual partners, injection drug users, and those living with someone who has hepatitis B, should undergo screening tests even if they have no symptoms. Early detection through laboratory testing allows for timely medical intervention and helps prevent the spread of infection to others.